Member Info for Inphobe

Lol, what a surprise to see you pop up last thing again MyLuck, repeating the sentiment of your post last thing Friday. I see other boards have got the measure of you.

Sorry clark, not clear what you're getting at?

Re PHE, all CE marked products are already in the PHE framework following the successful tender, I.e. 96 SARS-CoV-2 Kit, HCV ID Kit, MT-RNR1 ID Kit

Hence we await news on any orders on those through the framework

PoC will have to be added by request and agreement with PHE (the framework allows for this), I assume they will be doing this once released

No need, the platform is already there, the PoC is the Covid version. Both MT RNR1 (AIHL) and HCV tests run on the Genedrive instrument, as will the Covid PoC assay

https://www.genedrive.com/assays/rnr1-product.php

https://www.genedrive.com/assays/hcv-.php

https://www.genedrive.com/assays/in-development-genedrive-sars-cov-2.php

Factually incorrect

"The launch date is an estimation. The Company commented on a three month delay so it will be towards the end of the quarter."

Lol, just fluctuating in this range as it has been for weeks. Down on last w/e, but up on previous. Trading sideways in other words. As expected until news.

"You don't see the word bonanza very often" you don't, and I'm happily holding my stake here awaiting the progression of the summer drill with I think due excitement

Needs some I guess, but in the meantime holding and a nice pleasant board here, thank you! I dare say if the penny drops more widely it won't stay like this, you know what some of the lse forums are like when a stock gets active

Oh bore off guy

Lol MyLuck, I'm taking that as a joke (MyLuck...40...inevitable), but if you want one, how about 'back to 160, it's inevitable', see anyone can do it and imo more credible given the products in place and historic chart :)

Hey thanks rbr08, appreciate the info, good to know!

I'd love to know what is anticipated here

https://supply.unicef.org/s0003968.html

This entry appears to be just for the kit, with the instrument required separately but haven't been able to find an entry for the latter

Another area where we're currently in the dark. I heard it mentioned somewhere that they may be awaiting go-ahead to announce the long term arrangement that was spotted, but no idea if that's the case. Anyone spotted anything further?

(Equally, the PHE framework and guidance re AIHL should mean that product's coming to a good place, but hard to find any further information on that too)

I don't doubt current low sentiment due to lack of news drlong, but it's held in the 65-72 ish range for a good long while now. It held in a lower 40's range back over Christmas, with substantially less on the table. Whilst I agree we need news for a rise above this, you're putting out very low ball figures that the charts or anticipated news don't seem to support? I don't like predictions either way, but those lows you're talking about need proper justification just as much as high end predictions would. As jay says, right now it's just bobbing along here

This popped up

03-Jun-21 12:32:22 12.00 2,775,000 Sell* 333.00k

Nature has just published this article on Covid variants. Probably worth a look at for anyone involved in any Covid stocks

https://www.nature.com/articles/s41579-021-00573-0

Some of it makes for fairly troubling reading: "high probability of future mutation-mediated escape from host immunity"

(for avoidance of doubt, this is just for interest, I'm not implying anything!)

Hi BigAl, yeah, I remain very positive too but am as susceptible to frustration as us all! I think there's a good middle ground for companies to achieve with communication, and odx seem to be on the other side of it (I wish them well, but the frustration over on that board is palpable)

100% agree with you on communications or lack thereof Jaceorge (I know me agreeing may be a surprise, apologies!). There've been a few interesting things out there recently re AIHL, some liked by genedrive, but rarely directly mentioned by them. Not that excessive communication is always helpful either (see odx), but agree gdr badly need to up their game re shareholders

Blox, I wasn't implying anything, I said as much. Is it possible to find news about the way Covid is being handled interesting without being shot down here or has this board deteriorated that far? There's not much to talk about right now, and I found the 'rapid expansion of sequencing' interesting. If nothing else it shows that mutation of Covid is being taken very seriously going forward, which also does imply (if ones going to imply anything) the ongoing need for testing. It's just a discussion point, no need for argument, it's not controversial

I know, thanks blox (Hence I qualified with 'without jumping to any conclusions'). It is interesting to see where movement is in addressing Covid going forward, and at least relevant in that an organisation we are partnered with is getting a look in in this respect. We're otherwise quiet on news, so I think it's interesting enough and beats the usual arguments on here

This is certainly an interesting development as it stands, without jumping to any conclusions

(This is part of a critical project to rapidly expand the SARS-CoV-2 sequencing capacity under the Genomics testing expansion slated for the 2nd half of 2021.)